Stock Price
4.17
Daily Change
0.04 0.97%
Monthly
16.16%
Yearly
136.93%
Q2 Forecast
4.07

EDAP TMS reported EUR29.84M in Cash and Equivalent for its fiscal quarter ending in December of 2024.





Cash And Equivalent Change Date
AngioDynamics USD 41.64M 14.26M Sep/2025
Boston Scientific USD 1.45B 512M Mar/2026
EDAP TMS EUR 29.84M 4.35M Dec/2024
Henry Schein USD 138M 18M Mar/2026
Medtronic USD 1.15B 135M Dec/2025
Plus Therapeutics USD 3.02M 1.23M Mar/2026
Veracyte USD 263.14M 99.44M Mar/2026